Literature DB >> 22764020

What should we recommend to our patients with NAFLD regarding alcohol use?

Suthat Liangpunsakul1, Naga Chalasani.   

Abstract

It is generally recommended that patients with nonalcoholic fatty liver disease (NAFLD) not consume alcohol. However, because these patients are at increased cardiovascular risk, and light to moderate alcohol consumption may have hepatic benefits in people with or at risk for NAFLD, this recommendation may be ill-advised. We reviewed the literature on alcohol consumption and NAFLD and conclude that (i) heavy consumption has many harmful effects, including those on the liver, and should be discouraged whether a person has NAFLD or not; (ii) it is unknown whether cardiovascular and metabolic benefits of light to moderate consumption observed in the general population extend to those with NAFLD; (iii) epidemiological and cohort studies suggesting that light to moderate drinking may have hepatic benefits are largely cross-sectional and used surrogate end points; and (iv) until further data from rigorous prospective studies become available, people with NAFLD should avoid alcohol of any type or amount.

Entities:  

Mesh:

Year:  2012        PMID: 22764020      PMCID: PMC3766378          DOI: 10.1038/ajg.2012.20

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  27 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Authors:  Vera S G Ferreira; Ricardo B Pernambuco; Edmundo P Lopes; Clarice N Morais; Marbiana C Rodrigues; Maria Juliana Arruda; Lidiane Moura E Silva; Lucio Vilar
Journal:  Arq Bras Endocrinol Metabol       Date:  2010-06

3.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

4.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

5.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel E Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  N Engl J Med       Date:  2010-04-28       Impact factor: 91.245

Review 6.  Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.

Authors:  Nazim Ghouri; David Preiss; Naveed Sattar
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

7.  Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).

Authors:  Winston Dunn; Arun J Sanyal; Elizabeth M Brunt; Aynur Unalp-Arida; Michael Donohue; Arthur J McCullough; Jeffrey B Schwimmer
Journal:  J Hepatol       Date:  2012-04-17       Impact factor: 25.083

8.  Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.

Authors:  Mattias Ekstedt; Lennart E Franzén; Marika Holmqvist; Preben Bendtsen; Ulrik L Mathiesen; Göran Bodemar; Stergios Kechagias
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

9.  Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients.

Authors:  Helma P Cotrim; Luiz Antônio Freitas; Erivaldo Alves; Alessandro Almeida; Daniel S May; Stephen Caldwell
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-09       Impact factor: 2.566

10.  Alcohol consumption and digestive cancer mortality in Koreans: the Kangwha Cohort Study.

Authors:  Sang-Wook Yi; Jae Woong Sull; John Alderman Linton; Chung Mo Nam; Heechoul Ohrr
Journal:  J Epidemiol       Date:  2010-03-16       Impact factor: 3.211

View more
  18 in total

1.  The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease.

Authors:  Kirsten-Berit Linhart; Katharina Glassen; Teresa Peccerella; Rüdiger Waldherr; Heinz Linhart; Helmut Bartsch; Helmut K Seitz
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

2.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Authors: 
Journal:  Diabetologia       Date:  2016-06       Impact factor: 10.122

Review 3.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice.

Authors:  Gina Gough; Laura Heathers; Deonna Puckett; Chi Westerhold; Xiaowei Ren; Zhangsheng Yu; David W Crabb; Suthat Liangpunsakul
Journal:  Alcohol Clin Exp Res       Date:  2015-06-25       Impact factor: 3.455

Review 5.  Alcoholic liver disease.

Authors:  Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto
Journal:  Nat Rev Dis Primers       Date:  2018-08-16       Impact factor: 52.329

6.  Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.

Authors:  Danxia Yu; Xiao-Ou Shu; Yong-Bing Xiang; Honglan Li; Gong Yang; Yu-Tang Gao; Wei Zheng; Xianglan Zhang
Journal:  J Nutr       Date:  2014-10-15       Impact factor: 4.798

7.  Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis.

Authors:  Michael J Duryee; Monte S Willis; Courtney S Schaffert; Roger D Reidelberger; Anand Dusad; Daniel R Anderson; Lynell W Klassen; Geoffrey M Thiele
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-27       Impact factor: 4.052

Review 8.  Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD).

Authors:  Helmut K Seitz; Sebastian Mueller; Claus Hellerbrand; Suthat Liangpunsakul
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

9.  A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.

Authors:  Michelle T Long; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Jiantao Ma; Rohit Loomba; Raymond T Chung; Emelia J Benjamin
Journal:  Liver Int       Date:  2018-03-12       Impact factor: 5.828

10.  Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women.

Authors:  Sylvia H Ley; Qi Sun; Monik C Jimenez; Kathryn M Rexrode; Joann E Manson; Majken K Jensen; Eric B Rimm; Frank B Hu
Journal:  Diabetologia       Date:  2013-10-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.